Bavarian Nordic Berna GmbH

Founded in 1994, we have more than 25 years of experience in developing life-saving vaccines. We are a global leader in smallpox and monkeypox vaccines and our commercial product portfolio contains market-leading vaccines against rabies and tick-borne encephalitis as well as an Ebola vaccine. Our late-stage pipeline comprises a novel COVID-19 vaccine for boosting existing immunity and a vaccine against respiratory syncytial virus (RSV), for which no approved vaccines exist today. We are a global company headquartered in Denmark together with our state-of-the-art production facility and with sites in Germany, Switzerland, and USA. Our values – our Bavarian Nordic DNA, as we like to call it – is what guides our actions every day. We act as persistent pioneers, we are embracing change, we value being boosted by the team, and we believe in protecting lives every day. If that is also a part of your DNA, we invite you to join us in Bavarian Nordic! Bavarian Nordic is an Equal Opportunity Employer.